Načítá se...
Rational selection of biomarker driven therapies for gynecologic cancers: The more we know, the more we know we don’t know
Precision medicine is a rapidly evolving area in the treatment of gynecologic malignancies. Advances in sequencing technology have resulted in an increasing wealth of data regarding the genomic characteristics of ovarian, endometrial, and cervical cancers. These vast new datasets of information have...
Uloženo v:
| Vydáno v: | Gynecol Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4808566/ https://ncbi.nlm.nih.gov/pubmed/27016231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2016.01.003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|